DEVELOPMENT AND LICENSE AGREEMENT BETWEEN OPKO HEALTH, INC. AND VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD May 8, 2016Development and License Agreement • August 8th, 2016 • Opko Health, Inc. • Pharmaceutical preparations • New York
This Development and License Agreement (this “Agreement”) is entered into and effective as of the 8th day of May, 2016 (the “Effective Date”), by and between EirGen Pharma Limited, an entity formed under the laws of Ireland with registered seat at Westside Business, Old Kilmeaden, Waterford, Ireland (“OPKO”), and Vifor Fresenius Medical Care Renal Pharma Ltd, a corporation formed under the laws of Switzerland with registered seat at Rechenstrasse 37, 9014 St. Gallen, Switzerland (“VF”), for the development and marketing of OPKO’s Product in the Territory (as such terms are defined below).
